Stem cell therapy and tissue engineering for cardiovascular repair: From basic research to clinical applications

Abstract

Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair Dib, Taylor, Diethrich Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair serves as an essential reference material covering these emerging technologies in cardiovascular research. Written by prominent world authorities presenting commissioned summaries, Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair discusses the spectrum of stem cell and tissue engineering from basic research to clinical applications, offering a comprehensive, integrated reference. Key Features: Covers the fields of translational research and clinical applications including, - Pertinent information on cell isolation, expansion, and delivery, both in animals and humans - Overview of embryonic, bone marrow, and myoblast cell culturing and transplantation - Detailed explanations of the FDA regulatory pathways for cell production - Preclinical requirements for investigational new drug applications. - Regulatory requirements that can be applied to a variety of stem cell therapies Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair is essential for all cardiovascular research scientists, clinical researchers, and industry professionals wishing to take advantage of the latest and greatest in the continuously emerging field of stem cell therapy and tissue engineering for cardiovascular repair. the Editors: Nabil Dib, M.D., M.Sc, F.A.C.C, Director of Interventional Cardiology Research, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona Doris Taylor, Ph.D., Bakken Professor, Director, Center for Cardiovascular Repair, University of Minnesota, Minneapolis, Minnesota Edward B. Diethrich, M.D., Medical Director, Arizona Heart Institute and Heart Hospital, Phoenix, Arizona. © 2006 Springer Science+Business Media, Inc.